Structural and functional alteration of the gut microbiota in elderly patients with hyperlipidemia
Frontiers in Cellular and Infection Microbiology · 15.05.2024 · 14
DOI: 10.3389/fcimb.2024.1333145 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 15.05.2024. Verfasst von Meng Xia und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, First Affiliated Hospital, Dalian Medical University, Dalian, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Hyperlipidemias, RNA, Ribosomal, 16S, Feces. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To investigate the structure, composition, and functions of the gut microbiota in elderly patients with hyperlipidemia.
Methods
Sixteen older patients diagnosed with hyperlipidemia (M group) and 10 healthy, age-matched normal volunteers (N group) were included. These groups were further subdivided by sex into the male normal (NM, n = 5), female normal (NF, n = 5), male hyperlipidemia (MM, n = 8), and female hyperlipidemia (MF, n = 8) subgroups. Stool samples were collected for high-throughput sequencing of 16S rRNA genes. Blood samples were collected for clinical biochemical index testing.
Results
Alpha- and beta-diversity analyses revealed that the structure and composition of the gut microbiota were significantly different between the M and N groups. The relative abundances of Bacteroides , Parabacteroides , Blautia , Peptococcus , and Bifidobacterium were significantly decreased, while those of Lactobacillus , Helicobacter , and Desulfovibrio were significantly higher in the M group. There were also significant sex-related differences in microbial structure between the NM and NF groups, and between the MM and MF groups. Through functional prediction with PICRUSt 2, we observed distinct between-group variations in metabolic pathways associated with the gut microbiota and their impact on the functionality of the nervous system. Pearson’s correlation coefficient was used as a distance metric to build co-abundance networks. A hypergeometric test was used to detect taxonomies with significant enrichment in specific clusters. We speculated that modules with Muribaculaceae and Lachnospiraceae as the core microbes play an important ecological role in the intestinal microbiota of the M group. The relative intestinal abundances of Agathobacter and Faecalibacterium in the M group were positively correlated with serum triglyceride and low-density lipoprotein levels, while the relative abundance of Bifidobacterium was negatively correlated with the serum lipoprotein a level.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, First Affiliated Hospital, Dalian Medical University, Dalian, China.
- Department of Microecology, College of Basic Medical Sciences, Dalian Medical University, Dalian, China.
- Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
Zitieren
APA
Xia, M., Xu, Y., Li, H., Huang, J., Zhou, H., Gao, C., & Han, J. (2024). Structural and functional alteration of the gut microbiota in elderly patients with hyperlipidemia. Frontiers in Cellular and Infection Microbiology, 14. https://doi.org/10.3389/fcimb.2024.1333145
Vancouver
Xia M, Xu Y, Li H, Huang J, Zhou H, Gao C, et al. Structural and functional alteration of the gut microbiota in elderly patients with hyperlipidemia. Frontiers in Cellular and Infection Microbiology. 2024;14. doi:10.3389/fcimb.2024.1333145
BibTeX
@article{Xia2024,
author = {Xia, Meng and Xu, Yafang and Li, Huajun and Huang, Juan and Zhou, Haolin and Gao, Chuanzhou and Han, Jingyi},
title = {Structural and functional alteration of the gut microbiota in elderly patients with hyperlipidemia},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2024},
volume = {14},
doi = {10.3389/fcimb.2024.1333145}
}
EUVIMED